Occlutech Announces First Patient Enrollment in Important US Pivotal Study for the Atrial Flow Regulator (FROST-HF)

SCHAFFHAUSEN, CH / ACCESSWIRE / March 13, 2023 / Occlutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart disease devices, continues its progress in the US market. Today, the company has …